These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16720047)

  • 1. Homogeneous PCR nucleobase quenching assays to detect four mutations that cause neuronal ceroid lipofuscinosis: T75P and R151X in CLN1, and IVS5-1G>C and R208X in CLN2.
    Leman AR; Polochock S; Mole SE; Pearce DA; Rothberg PG
    J Neurosci Methods; 2006 Oct; 157(1):124-31. PubMed ID: 16720047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
    Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal ceroid lipofuscinoses: research update.
    Wisniewski KE; Kida E; Connell F; Zhong N
    Neurol Sci; 2000; 21(3 Suppl):S49-56. PubMed ID: 11073228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
    Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
    Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population.
    Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG
    J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Australasian diagnostic service for the neuronal ceroid lipofuscinoses.
    Muller VJ; Paton BC; Fietz MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():197-201. PubMed ID: 11588997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.
    Zhong N; Moroziewicz DN; Ju W; Jurkiewicz A; Johnston L; Wisniewski KE; Brown WT
    Genet Med; 2000; 2(6):312-8. PubMed ID: 11339651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
    Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
    Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.
    Mole SE; Williams RE; Goebel HH
    Neurogenetics; 2005 Sep; 6(3):107-26. PubMed ID: 15965709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland.
    Moore SJ; Buckley DJ; MacMillan A; Marshall HD; Steele L; Ray PN; Nawaz Z; Baskin B; Frecker M; Carr SM; Ives E; Parfrey PS
    Clin Genet; 2008 Sep; 74(3):213-22. PubMed ID: 18684116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
    Chattopadhyay S; Pearce DA
    Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal ceroid-lipofuscinoses.
    Bennett MJ; Rakheja D
    Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of and carrier screening for the neuronal ceroid lipofuscinoses.
    Zhong NA; Wisniewski KE; Ju W; Moroziewicz DN; Jurkiewicz A; McLendon L; Jenkins EC; Brown WT
    Genet Test; 2000; 4(3):243-8. PubMed ID: 11142754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression in colorectal carcinoma of two lysosomal enzymes, CLN2 and CLN1, involved in neuronal ceroid lipofuscinosis.
    Tsukamoto T; Iida J; Dobashi Y; Furukawa T; Konishi F
    Cancer; 2006 Apr; 106(7):1489-97. PubMed ID: 16518810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetic basis of the neuronal ceroid lipofuscinoses.
    Gardiner RM
    Neurol Sci; 2000; 21(3 Suppl):S15-9. PubMed ID: 11073223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic spectrum of human neuronal ceroid-lipofuscinoses.
    Mole SE
    Brain Pathol; 2004 Jan; 14(1):70-6. PubMed ID: 14997939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.
    Yu F; Liu XM; Chen YH; Zhang SQ; Wang K
    Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.